

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.31926715 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.19269481 |
| 3 | cellular response to arsenic-containing substance (GO:0071243) | 4.16984496 |
| 4 | mitotic metaphase plate congression (GO:0007080) | 4.05592966 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.04585902 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 3.98284983 |
| 7 | positive regulation of protein homooligomerization (GO:0032464) | 3.97381876 |
| 8 | purine nucleobase biosynthetic process (GO:0009113) | 3.88010342 |
| 9 | protein localization to kinetochore (GO:0034501) | 3.87879467 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 3.85345379 |
| 11 | DNA replication initiation (GO:0006270) | 3.81310815 |
| 12 | metaphase plate congression (GO:0051310) | 3.76506170 |
| 13 | mitotic nuclear envelope disassembly (GO:0007077) | 3.75611853 |
| 14 | IMP biosynthetic process (GO:0006188) | 3.75132964 |
| 15 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.74407867 |
| 16 | ribosome biogenesis (GO:0042254) | 3.73382593 |
| 17 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.72562128 |
| 18 | nuclear pore organization (GO:0006999) | 3.71542413 |
| 19 | DNA replication checkpoint (GO:0000076) | 3.66552899 |
| 20 | nuclear pore complex assembly (GO:0051292) | 3.63399521 |
| 21 | DNA strand elongation (GO:0022616) | 3.63117414 |
| 22 | ribosomal small subunit assembly (GO:0000028) | 3.55062045 |
| 23 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.54601714 |
| 24 | protein localization to chromosome, centromeric region (GO:0071459) | 3.47080424 |
| 25 | nuclear envelope disassembly (GO:0051081) | 3.45988567 |
| 26 | membrane disassembly (GO:0030397) | 3.45988567 |
| 27 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.45648729 |
| 28 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.45648729 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 3.45245407 |
| 30 | germinal center formation (GO:0002467) | 3.42442344 |
| 31 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41566057 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37567412 |
| 33 | ribosome assembly (GO:0042255) | 3.37500815 |
| 34 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.37322548 |
| 35 | establishment of chromosome localization (GO:0051303) | 3.33460842 |
| 36 | regulation of spindle organization (GO:0090224) | 3.31777903 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31340475 |
| 38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.26215973 |
| 39 | telomere maintenance via recombination (GO:0000722) | 3.26014941 |
| 40 | DNA deamination (GO:0045006) | 3.25796444 |
| 41 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.25572328 |
| 42 | CENP-A containing nucleosome assembly (GO:0034080) | 3.24941269 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.21443797 |
| 44 | chromatin remodeling at centromere (GO:0031055) | 3.20927450 |
| 45 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.18628163 |
| 46 | rRNA modification (GO:0000154) | 3.15443210 |
| 47 | DNA replication-independent nucleosome organization (GO:0034724) | 3.15441353 |
| 48 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.15441353 |
| 49 | IMP metabolic process (GO:0046040) | 3.13706974 |
| 50 | mitotic chromosome condensation (GO:0007076) | 3.12871194 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.09370751 |
| 52 | mitotic recombination (GO:0006312) | 3.08943590 |
| 53 | ribosomal large subunit biogenesis (GO:0042273) | 3.06433464 |
| 54 | kinetochore organization (GO:0051383) | 3.06414170 |
| 55 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.05404379 |
| 56 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.02081328 |
| 57 | proteasome assembly (GO:0043248) | 3.01141572 |
| 58 | negative regulation of interleukin-1 production (GO:0032692) | 2.99683008 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99538907 |
| 60 | pore complex assembly (GO:0046931) | 2.98412067 |
| 61 | telomere maintenance via telomere lengthening (GO:0010833) | 2.98326066 |
| 62 | protein K6-linked ubiquitination (GO:0085020) | 2.95812126 |
| 63 | leukocyte aggregation (GO:0070486) | 2.94327431 |
| 64 | neutrophil mediated immunity (GO:0002446) | 2.94048194 |
| 65 | rRNA processing (GO:0006364) | 2.92586734 |
| 66 | activation of MAPKKK activity (GO:0000185) | 2.92519800 |
| 67 | spliceosomal snRNP assembly (GO:0000387) | 2.90366381 |
| 68 | regulation of mitotic spindle organization (GO:0060236) | 2.88877084 |
| 69 | rRNA metabolic process (GO:0016072) | 2.85409003 |
| 70 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.84887558 |
| 71 | negative regulation of interleukin-6 production (GO:0032715) | 2.83854557 |
| 72 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.82254687 |
| 73 | viral mRNA export from host cell nucleus (GO:0046784) | 2.81858125 |
| 74 | kinetochore assembly (GO:0051382) | 2.81360319 |
| 75 | RNA destabilization (GO:0050779) | 2.80655410 |
| 76 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80287496 |
| 77 | negative regulation of interleukin-8 production (GO:0032717) | 2.80083104 |
| 78 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.79869086 |
| 79 | protein localization to chromosome (GO:0034502) | 2.78931644 |
| 80 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.78663330 |
| 81 | rRNA methylation (GO:0031167) | 2.78585108 |
| 82 | termination of RNA polymerase I transcription (GO:0006363) | 2.76886940 |
| 83 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.76397460 |
| 84 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.76397460 |
| 85 | cellular extravasation (GO:0045123) | 2.75191511 |
| 86 | histone exchange (GO:0043486) | 2.73570526 |
| 87 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.73385681 |
| 88 | regulation of B cell apoptotic process (GO:0002902) | 2.72217351 |
| 89 | granulocyte activation (GO:0036230) | 2.72041337 |
| 90 | spindle checkpoint (GO:0031577) | 2.71278328 |
| 91 | maturation of 5.8S rRNA (GO:0000460) | 2.70465247 |
| 92 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.70408210 |
| 93 | nuclear envelope organization (GO:0006998) | 2.69992827 |
| 94 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.69714590 |
| 95 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.69171993 |
| 96 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.68410828 |
| 97 | meiotic chromosome segregation (GO:0045132) | 2.67960315 |
| 98 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.67728064 |
| 99 | 7-methylguanosine mRNA capping (GO:0006370) | 2.67646594 |
| 100 | termination of RNA polymerase III transcription (GO:0006386) | 2.65586758 |
| 101 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.65586758 |
| 102 | neutrophil activation involved in immune response (GO:0002283) | 2.65458457 |
| 103 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.63891355 |
| 104 | RNA splicing, via transesterification reactions (GO:0000375) | 2.62868829 |
| 105 | regulation of necroptotic process (GO:0060544) | 2.62421250 |
| 106 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.62169781 |
| 107 | cell cycle G1/S phase transition (GO:0044843) | 2.62169781 |
| 108 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.62018100 |
| 109 | positive regulation of chromosome segregation (GO:0051984) | 2.61509749 |
| 110 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.61384738 |
| 111 | mitotic sister chromatid segregation (GO:0000070) | 2.61151904 |
| 112 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.60942520 |
| 113 | mRNA splicing, via spliceosome (GO:0000398) | 2.60942520 |
| 114 | translational initiation (GO:0006413) | 2.60377519 |
| 115 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.60279612 |
| 116 | transcription from RNA polymerase I promoter (GO:0006360) | 2.59526105 |
| 117 | oligosaccharide catabolic process (GO:0009313) | 2.59446032 |
| 118 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.59181178 |
| 119 | mitotic spindle checkpoint (GO:0071174) | 2.58641563 |
| 120 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.58479862 |
| 121 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.58479862 |
| 122 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.58479862 |
| 123 | negative regulation of sister chromatid segregation (GO:0033046) | 2.58479862 |
| 124 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.58472525 |
| 125 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.58119745 |
| 126 | negative regulation of chromosome segregation (GO:0051985) | 2.58113540 |
| 127 | regulation of necrotic cell death (GO:0010939) | 2.57816880 |
| 128 | RNA capping (GO:0036260) | 2.57655018 |
| 129 | 7-methylguanosine RNA capping (GO:0009452) | 2.57655018 |
| 130 | telomere organization (GO:0032200) | 2.57587814 |
| 131 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.57513084 |
| 132 | telomere maintenance (GO:0000723) | 2.57049140 |
| 133 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.56396931 |
| 134 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.56239690 |
| 135 | spliceosomal complex assembly (GO:0000245) | 2.56001639 |
| 136 | tRNA methylation (GO:0030488) | 2.55510608 |
| 137 | regulation of vitamin metabolic process (GO:0030656) | 2.55494199 |
| 138 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55175807 |
| 139 | regulation of mast cell activation (GO:0033003) | 2.54755531 |
| 140 | DNA synthesis involved in DNA repair (GO:0000731) | 2.54746496 |
| 141 | ribosomal small subunit biogenesis (GO:0042274) | 2.54599237 |
| 142 | positive regulation of defense response to virus by host (GO:0002230) | 2.54520461 |
| 143 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.53843017 |
| 144 | regulation of helicase activity (GO:0051095) | 2.53063100 |
| 145 | folic acid metabolic process (GO:0046655) | 2.52938950 |
| 146 | positive regulation of protein oligomerization (GO:0032461) | 2.50369737 |
| 147 | positive regulation of interleukin-2 production (GO:0032743) | 2.50267350 |
| 148 | positive regulation of heat generation (GO:0031652) | 2.48850564 |
| 149 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.47101511 |
| 150 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.46655073 |
| 151 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.46655073 |
| 152 | detection of molecule of bacterial origin (GO:0032490) | 2.46235744 |
| 153 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45504151 |
| 154 | positive regulation of p38MAPK cascade (GO:1900745) | 2.44718643 |
| 155 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.42749053 |
| 156 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42425648 |
| 157 | regulation of mast cell degranulation (GO:0043304) | 2.42360816 |
| 158 | neutrophil activation (GO:0042119) | 2.40813622 |
| 159 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40476656 |
| 160 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.40319143 |
| 161 | negative regulation of inclusion body assembly (GO:0090084) | 2.39695677 |
| 162 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.39405972 |
| 163 | myeloid leukocyte mediated immunity (GO:0002444) | 2.37990175 |
| 164 | response to arsenic-containing substance (GO:0046685) | 2.37966075 |
| 165 | negative regulation of cell killing (GO:0031342) | 2.37160055 |
| 166 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.37160055 |
| 167 | negative regulation of necroptotic process (GO:0060546) | 2.35756836 |
| 168 | regulation of defense response to virus by host (GO:0050691) | 2.35477733 |
| 169 | response to acidic pH (GO:0010447) | 2.34942011 |
| 170 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.34701482 |
| 171 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.34635138 |
| 172 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.34635138 |
| 173 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.34635138 |
| 174 | modulation by symbiont of host immune response (GO:0052553) | 2.34635138 |
| 175 | positive regulation by symbiont of host defense response (GO:0052509) | 2.34635138 |
| 176 | modulation by symbiont of host defense response (GO:0052031) | 2.34635138 |
| 177 | B cell mediated immunity (GO:0019724) | 2.33933846 |
| 178 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.33728663 |
| 179 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.32893403 |
| 180 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.32098787 |
| 181 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.30757957 |
| 182 | regulation of gamma-delta T cell activation (GO:0046643) | 2.30180134 |
| 183 | purine nucleotide salvage (GO:0032261) | 2.28980426 |
| 184 | natural killer cell activation involved in immune response (GO:0002323) | 2.28593478 |
| 185 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.28286410 |
| 186 | interferon-gamma production (GO:0032609) | 2.28088578 |
| 187 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.27547878 |
| 188 | regulation of interleukin-1 secretion (GO:0050704) | 2.23422967 |
| 189 | positive regulation of macrophage differentiation (GO:0045651) | 2.23124368 |
| 190 | macrophage activation involved in immune response (GO:0002281) | 2.22975150 |
| 191 | negative regulation of necrotic cell death (GO:0060547) | 2.22168088 |
| 192 | myeloid cell activation involved in immune response (GO:0002275) | 2.22058327 |
| 193 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.21868792 |
| 194 | leukocyte degranulation (GO:0043299) | 2.21276936 |
| 195 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.19618522 |
| 196 | cellular response to molecule of bacterial origin (GO:0071219) | 2.19571403 |
| 197 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.19568019 |
| 198 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.18760100 |
| 199 | cellular response to lipopolysaccharide (GO:0071222) | 2.17807484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.45051443 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.25603219 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.04694885 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.63261514 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.25995040 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.20702311 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.96083109 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.92934120 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79764522 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.77118689 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.76673452 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75996177 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.72612881 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.70045151 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.65705105 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.64383590 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62738079 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.61802046 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.61268580 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.59861074 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57673446 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.46912696 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35248977 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.24865076 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.22806105 |
| 26 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.21099854 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.19557161 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18280665 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13622834 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13290292 |
| 31 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11582289 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09590486 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.07990191 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 2.02701383 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99483675 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97822339 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96878738 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95877383 |
| 39 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.90739988 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.89560193 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87939332 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87889815 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.87588023 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.87558234 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86849479 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85701626 |
| 47 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.82681460 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82472812 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82220734 |
| 50 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81673971 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.79456195 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.78421319 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77746822 |
| 54 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.73857834 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73732603 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72892358 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71563937 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.69650834 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67643429 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67623843 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.66817724 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.65562119 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64894088 |
| 64 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.64490731 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63316058 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61858380 |
| 67 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.59970787 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58576929 |
| 69 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.56220098 |
| 70 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53547125 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52159352 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.51369395 |
| 73 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51054683 |
| 74 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49890363 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49556772 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49503953 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48329237 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44503032 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44055863 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43124909 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42703086 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42149835 |
| 83 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.41998947 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40441260 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39801294 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38768872 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38526534 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37992762 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37614372 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37166728 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35382086 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33188743 |
| 93 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32152920 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32130403 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31530586 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29544881 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27726867 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27023207 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25498389 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23912311 |
| 101 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22865638 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21809267 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20885027 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20078348 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19986972 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19277048 |
| 107 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19010458 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18621878 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18318175 |
| 110 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18160867 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17939239 |
| 112 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.17712266 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17556009 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17365608 |
| 115 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16183961 |
| 116 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.16116574 |
| 117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15787732 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14966786 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14523142 |
| 120 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14471795 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11845241 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.11822604 |
| 123 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11202073 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11058334 |
| 125 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10953480 |
| 126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10849354 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10618558 |
| 128 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10137687 |
| 129 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09761253 |
| 130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09405445 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09215647 |
| 132 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08782912 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08305480 |
| 134 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07478526 |
| 135 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07447505 |
| 136 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07394251 |
| 137 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07171110 |
| 138 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06968387 |
| 139 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06874423 |
| 140 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06382143 |
| 141 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05521679 |
| 142 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05151459 |
| 143 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04935079 |
| 144 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04310521 |
| 145 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03291162 |
| 146 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01289248 |
| 147 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99733275 |
| 148 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98057987 |
| 149 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98022072 |
| 150 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95445979 |
| 151 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94251408 |
| 152 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93760581 |
| 153 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93528695 |
| 154 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92645314 |
| 155 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89856912 |
| 156 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88707841 |
| 157 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88379363 |
| 158 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85026376 |
| 159 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.84264582 |
| 160 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81588403 |
| 161 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.80996100 |
| 162 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.78192806 |
| 163 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77748049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.61031661 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.74113791 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.64163702 |
| 4 | MP0003077_abnormal_cell_cycle | 3.42599801 |
| 5 | MP0003646_muscle_fatigue | 3.26651385 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.18375973 |
| 7 | MP0003303_peritoneal_inflammation | 3.06961372 |
| 8 | MP0008007_abnormal_cellular_replicative | 2.86388234 |
| 9 | MP0008058_abnormal_DNA_repair | 2.78324336 |
| 10 | MP0008057_abnormal_DNA_replication | 2.76810756 |
| 11 | MP0009840_abnormal_foam_cell | 2.73540027 |
| 12 | MP0003123_paternal_imprinting | 2.58206360 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.50522278 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.33357047 |
| 15 | MP0004510_myositis | 2.27636440 |
| 16 | MP0009785_altered_susceptibility_to | 2.26089909 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.20876439 |
| 18 | MP0003724_increased_susceptibility_to | 2.18449715 |
| 19 | * MP0002419_abnormal_innate_immunity | 2.14857785 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.06062106 |
| 21 | MP0002723_abnormal_immune_serum | 2.06032853 |
| 22 | MP0001730_embryonic_growth_arrest | 2.02947605 |
| 23 | MP0002332_abnormal_exercise_endurance | 2.01715981 |
| 24 | MP0005025_abnormal_response_to | 1.97985201 |
| 25 | MP0006082_CNS_inflammation | 1.96844733 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.96145129 |
| 27 | MP0001800_abnormal_humoral_immune | 1.95972781 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.93142668 |
| 29 | MP0010030_abnormal_orbit_morphology | 1.92184412 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.91749438 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.90208790 |
| 32 | MP0000350_abnormal_cell_proliferation | 1.86530933 |
| 33 | * MP0002452_abnormal_antigen_presenting | 1.83472670 |
| 34 | MP0003786_premature_aging | 1.80816962 |
| 35 | MP0009764_decreased_sensitivity_to | 1.78563990 |
| 36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.76173821 |
| 37 | * MP0001819_abnormal_immune_cell | 1.74537820 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.70842314 |
| 39 | MP0005380_embryogenesis_phenotype | 1.68724000 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.68724000 |
| 41 | MP0000749_muscle_degeneration | 1.68675802 |
| 42 | MP0005330_cardiomyopathy | 1.67827264 |
| 43 | MP0004233_abnormal_muscle_weight | 1.67366593 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.67215361 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.66420095 |
| 46 | MP0010307_abnormal_tumor_latency | 1.61623788 |
| 47 | MP0003984_embryonic_growth_retardation | 1.60966788 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.58104303 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.56254956 |
| 50 | MP0001697_abnormal_embryo_size | 1.55530355 |
| 51 | MP0003121_genomic_imprinting | 1.55450738 |
| 52 | MP0001853_heart_inflammation | 1.55297023 |
| 53 | MP0005387_immune_system_phenotype | 1.55049542 |
| 54 | MP0001790_abnormal_immune_system | 1.55049542 |
| 55 | MP0004947_skin_inflammation | 1.52676772 |
| 56 | MP0008260_abnormal_autophagy | 1.48895106 |
| 57 | MP0000343_altered_response_to | 1.46950572 |
| 58 | MP0000750_abnormal_muscle_regeneration | 1.46801354 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.46633385 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.45246305 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.43916757 |
| 62 | MP0005310_abnormal_salivary_gland | 1.40275667 |
| 63 | MP0002080_prenatal_lethality | 1.40239921 |
| 64 | MP0000490_abnormal_crypts_of | 1.38882567 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 1.38623533 |
| 66 | MP0003075_altered_response_to | 1.34100646 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.33376332 |
| 68 | MP0004484_altered_response_of | 1.30472886 |
| 69 | MP0008469_abnormal_protein_level | 1.29455433 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.28698445 |
| 71 | MP0000685_abnormal_immune_system | 1.28623754 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.27655513 |
| 73 | MP0002085_abnormal_embryonic_tissue | 1.27227707 |
| 74 | * MP0000313_abnormal_cell_death | 1.27149013 |
| 75 | MP0003718_maternal_effect | 1.26311977 |
| 76 | * MP0004197_abnormal_fetal_growth/weight/ | 1.25480296 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.25294707 |
| 78 | MP0002084_abnormal_developmental_patter | 1.18826225 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.18798722 |
| 80 | MP0005670_abnormal_white_adipose | 1.18779054 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.16560210 |
| 82 | MP0004036_abnormal_muscle_relaxation | 1.14477865 |
| 83 | MP0002019_abnormal_tumor_incidence | 1.14378431 |
| 84 | * MP0001293_anophthalmia | 1.13992295 |
| 85 | MP0002210_abnormal_sex_determination | 1.10193345 |
| 86 | MP0000747_muscle_weakness | 1.04295360 |
| 87 | MP0005410_abnormal_fertilization | 1.01417205 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 1.01416411 |
| 89 | MP0005408_hypopigmentation | 1.01031814 |
| 90 | MP0002269_muscular_atrophy | 1.00524954 |
| 91 | MP0002160_abnormal_reproductive_system | 1.00170901 |
| 92 | MP0004084_abnormal_cardiac_muscle | 0.99891030 |
| 93 | MP0002938_white_spotting | 0.99591989 |
| 94 | * MP0000703_abnormal_thymus_morphology | 0.98442216 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.97945301 |
| 96 | MP0009697_abnormal_copulation | 0.97397751 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97095760 |
| 98 | MP0002398_abnormal_bone_marrow | 0.96842620 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.96709438 |
| 100 | MP0005023_abnormal_wound_healing | 0.95180743 |
| 101 | MP0001119_abnormal_female_reproductive | 0.94263631 |
| 102 | MP0003943_abnormal_hepatobiliary_system | 0.93885131 |
| 103 | MP0005671_abnormal_response_to | 0.93601744 |
| 104 | MP0001929_abnormal_gametogenesis | 0.93571129 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 0.93350043 |
| 106 | MP0006054_spinal_hemorrhage | 0.93293541 |
| 107 | MP0009672_abnormal_birth_weight | 0.92913441 |
| 108 | MP0004087_abnormal_muscle_fiber | 0.92751236 |
| 109 | MP0003828_pulmonary_edema | 0.92700221 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.92544499 |
| 111 | MP0004130_abnormal_muscle_cell | 0.92536998 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.92155476 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.92155476 |
| 114 | MP0001915_intracranial_hemorrhage | 0.91744848 |
| 115 | MP0005083_abnormal_biliary_tract | 0.91024270 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.90669648 |
| 117 | MP0002127_abnormal_cardiovascular_syste | 0.89530461 |
| 118 | MP0000689_abnormal_spleen_morphology | 0.89457807 |
| 119 | MP0001145_abnormal_male_reproductive | 0.89372990 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.89128507 |
| 121 | * MP0002722_abnormal_immune_system | 0.88959093 |
| 122 | MP0002106_abnormal_muscle_physiology | 0.88403199 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.88263563 |
| 124 | MP0002653_abnormal_ependyma_morphology | 0.87846309 |
| 125 | MP0000371_diluted_coat_color | 0.87402661 |
| 126 | MP0003315_abnormal_perineum_morphology | 0.87158406 |
| 127 | MP0000372_irregular_coat_pigmentation | 0.87061412 |
| 128 | MP0000759_abnormal_skeletal_muscle | 0.85283672 |
| 129 | MP0005166_decreased_susceptibility_to | 0.84689617 |
| 130 | MP0001501_abnormal_sleep_pattern | 0.84576100 |
| 131 | MP0000858_altered_metastatic_potential | 0.84385613 |
| 132 | MP0005266_abnormal_metabolism | 0.83305900 |
| 133 | MP0003045_fibrosis | 0.82751236 |
| 134 | MP0000569_abnormal_digit_pigmentation | 0.82546937 |
| 135 | MP0001502_abnormal_circadian_rhythm | 0.81646565 |
| 136 | MP0002138_abnormal_hepatobiliary_system | 0.81093263 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.80780792 |
| 138 | MP0000653_abnormal_sex_gland | 0.80589019 |
| 139 | MP0008004_abnormal_stomach_pH | 0.79875459 |
| 140 | MP0003937_abnormal_limbs/digits/tail_de | 0.79015095 |
| 141 | MP0002972_abnormal_cardiac_muscle | 0.79008118 |
| 142 | MP0004215_abnormal_myocardial_fiber | 0.77936077 |
| 143 | MP0000751_myopathy | 0.77744888 |
| 144 | MP0000604_amyloidosis | 0.76866713 |
| 145 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76546210 |
| 146 | * MP0002429_abnormal_blood_cell | 0.76519800 |
| 147 | MP0003186_abnormal_redox_activity | 0.75823152 |
| 148 | MP0009763_increased_sensitivity_to | 0.75064848 |
| 149 | MP0009053_abnormal_anal_canal | 0.75060811 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.74816552 |
| 151 | MP0002405_respiratory_system_inflammati | 0.74781965 |
| 152 | MP0003195_calcinosis | 0.74710144 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.74384781 |
| 154 | * MP0002092_abnormal_eye_morphology | 0.72910813 |
| 155 | MP0005389_reproductive_system_phenotype | 0.72661536 |
| 156 | MP0002111_abnormal_tail_morphology | 0.72212791 |
| 157 | MP0000358_abnormal_cell_content/ | 0.71741289 |
| 158 | MP0002925_abnormal_cardiovascular_devel | 0.71338798 |
| 159 | MP0003119_abnormal_digestive_system | 0.69610373 |
| 160 | MP0005384_cellular_phenotype | 0.67798425 |
| 161 | MP0001186_pigmentation_phenotype | 0.66073008 |
| 162 | MP0003941_abnormal_skin_development | 0.65006623 |
| 163 | MP0009278_abnormal_bone_marrow | 0.64971847 |
| 164 | MP0000716_abnormal_immune_system | 0.64678943 |
| 165 | MP0005451_abnormal_body_composition | 0.64592205 |
| 166 | MP0001286_abnormal_eye_development | 0.64538611 |
| 167 | MP0002075_abnormal_coat/hair_pigmentati | 0.63379134 |
| 168 | MP0005621_abnormal_cell_physiology | 0.62412835 |
| 169 | MP0005076_abnormal_cell_differentiation | 0.61982809 |
| 170 | MP0003806_abnormal_nucleotide_metabolis | 0.60944046 |
| 171 | MP0003436_decreased_susceptibility_to | 0.60551256 |
| 172 | MP0000767_abnormal_smooth_muscle | 0.58914494 |
| 173 | MP0004133_heterotaxia | 0.58613675 |
| 174 | * MP0002420_abnormal_adaptive_immunity | 0.58417052 |
| 175 | MP0000516_abnormal_urinary_system | 0.57846672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.39273697 |
| 2 | Stomatitis (HP:0010280) | 4.21848617 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 4.12754079 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.84970606 |
| 5 | Myositis (HP:0100614) | 3.60094807 |
| 6 | Optic neuritis (HP:0100653) | 3.58843130 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.58843130 |
| 8 | Orchitis (HP:0100796) | 3.52938840 |
| 9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.49724143 |
| 10 | Degeneration of anterior horn cells (HP:0002398) | 3.48552350 |
| 11 | Abnormality of the anterior horn cell (HP:0006802) | 3.48552350 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47287602 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47287602 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47287602 |
| 15 | Chromsome breakage (HP:0040012) | 3.40162274 |
| 16 | Breast hypoplasia (HP:0003187) | 3.30018885 |
| 17 | Reticulocytopenia (HP:0001896) | 3.29256027 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.22126362 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.15153736 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.13789771 |
| 21 | Patellar aplasia (HP:0006443) | 3.08334642 |
| 22 | Aplastic anemia (HP:0001915) | 3.07963549 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.02344942 |
| 24 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.98281959 |
| 25 | Amyloidosis (HP:0011034) | 2.95535314 |
| 26 | Carpal bone hypoplasia (HP:0001498) | 2.95530761 |
| 27 | 11 pairs of ribs (HP:0000878) | 2.86674359 |
| 28 | Colon cancer (HP:0003003) | 2.84015003 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.81931902 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.78468929 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77703034 |
| 32 | Meckel diverticulum (HP:0002245) | 2.75722890 |
| 33 | Selective tooth agenesis (HP:0001592) | 2.70718174 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.69870767 |
| 35 | Syringomyelia (HP:0003396) | 2.64359105 |
| 36 | Spinal cord lesions (HP:0100561) | 2.64359105 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.63171268 |
| 38 | Progressive muscle weakness (HP:0003323) | 2.62592347 |
| 39 | Impulsivity (HP:0100710) | 2.62537084 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.61406961 |
| 41 | Abnormality of the ileum (HP:0001549) | 2.61357996 |
| 42 | Increased serum ferritin (HP:0003281) | 2.60577679 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.59573995 |
| 44 | Fatigue (HP:0012378) | 2.58776633 |
| 45 | Medulloblastoma (HP:0002885) | 2.56568546 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.52861301 |
| 47 | Myoglobinuria (HP:0002913) | 2.51413867 |
| 48 | Abnormality of chromosome stability (HP:0003220) | 2.49674897 |
| 49 | Abnormality of the preputium (HP:0100587) | 2.46037294 |
| 50 | Episodic fever (HP:0001954) | 2.45184816 |
| 51 | Cerebral hypomyelination (HP:0006808) | 2.43754812 |
| 52 | Rough bone trabeculation (HP:0100670) | 2.43254129 |
| 53 | Absent thumb (HP:0009777) | 2.42812811 |
| 54 | Upper limb muscle weakness (HP:0003484) | 2.41926159 |
| 55 | Loss of speech (HP:0002371) | 2.41675753 |
| 56 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.41044326 |
| 57 | Cholecystitis (HP:0001082) | 2.38972458 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.38972458 |
| 59 | Ragged-red muscle fibers (HP:0003200) | 2.37390656 |
| 60 | Premature graying of hair (HP:0002216) | 2.36786986 |
| 61 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.33091534 |
| 62 | Myelodysplasia (HP:0002863) | 2.33058990 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.33028923 |
| 64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.30985730 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30751013 |
| 66 | Obstructive lung disease (HP:0006536) | 2.30751013 |
| 67 | Acute hepatic failure (HP:0006554) | 2.30440130 |
| 68 | Muscle fiber inclusion bodies (HP:0100299) | 2.28805220 |
| 69 | Abnormality of the umbilical cord (HP:0010881) | 2.28308626 |
| 70 | Ectopic kidney (HP:0000086) | 2.27580325 |
| 71 | Abnormality of the calcaneus (HP:0008364) | 2.26101709 |
| 72 | EMG: myopathic abnormalities (HP:0003458) | 2.23165113 |
| 73 | Absent radius (HP:0003974) | 2.22416149 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20498109 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20498109 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20498109 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.18387595 |
| 78 | Bone marrow hypocellularity (HP:0005528) | 2.18332437 |
| 79 | Abnormal lung lobation (HP:0002101) | 2.18081303 |
| 80 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15699937 |
| 81 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.15038156 |
| 82 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.15038156 |
| 83 | Single umbilical artery (HP:0001195) | 2.15038156 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.11881676 |
| 85 | Nausea (HP:0002018) | 2.11227669 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09827181 |
| 87 | Nemaline bodies (HP:0003798) | 2.09611932 |
| 88 | Neoplasm of the pancreas (HP:0002894) | 2.08929054 |
| 89 | Vasculitis (HP:0002633) | 2.08691757 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.06918305 |
| 91 | Granulocytopenia (HP:0001913) | 2.06344752 |
| 92 | Sloping forehead (HP:0000340) | 2.05932715 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.05166153 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.04649932 |
| 95 | Aplasia involving forearm bones (HP:0009822) | 2.04320150 |
| 96 | Absent forearm bone (HP:0003953) | 2.04320150 |
| 97 | Trismus (HP:0000211) | 2.04089890 |
| 98 | Thrombocytosis (HP:0001894) | 2.03974382 |
| 99 | Polyneuropathy (HP:0001271) | 2.03914710 |
| 100 | Myopathic facies (HP:0002058) | 2.03029223 |
| 101 | Duodenal stenosis (HP:0100867) | 2.02631476 |
| 102 | Small intestinal stenosis (HP:0012848) | 2.02631476 |
| 103 | Abnormality of the endocardium (HP:0004306) | 2.00760079 |
| 104 | Encephalitis (HP:0002383) | 2.00254615 |
| 105 | Diaphragmatic weakness (HP:0009113) | 1.99760541 |
| 106 | Hemoptysis (HP:0002105) | 1.98251714 |
| 107 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97996379 |
| 108 | Muscle fiber splitting (HP:0003555) | 1.96731978 |
| 109 | Amaurosis fugax (HP:0100576) | 1.96426724 |
| 110 | Supernumerary spleens (HP:0009799) | 1.96009179 |
| 111 | Ependymoma (HP:0002888) | 1.95562590 |
| 112 | Basal cell carcinoma (HP:0002671) | 1.94668853 |
| 113 | Abnormality of glycolysis (HP:0004366) | 1.93903291 |
| 114 | Keratitis (HP:0000491) | 1.93658735 |
| 115 | Increased IgM level (HP:0003496) | 1.93175226 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92631468 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 1.92631468 |
| 118 | Hyperalaninemia (HP:0003348) | 1.92631468 |
| 119 | Cutaneous melanoma (HP:0012056) | 1.91838413 |
| 120 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.91598907 |
| 121 | Frequent falls (HP:0002359) | 1.91355450 |
| 122 | Neuronal loss in central nervous system (HP:0002529) | 1.91338990 |
| 123 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.90783028 |
| 124 | Increased serum pyruvate (HP:0003542) | 1.90161003 |
| 125 | Leukocytosis (HP:0001974) | 1.89950387 |
| 126 | Optic nerve coloboma (HP:0000588) | 1.89355362 |
| 127 | Horseshoe kidney (HP:0000085) | 1.87699860 |
| 128 | Agnosia (HP:0010524) | 1.87495752 |
| 129 | Microretrognathia (HP:0000308) | 1.87180434 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.87142229 |
| 131 | Glossoptosis (HP:0000162) | 1.87060848 |
| 132 | Progressive external ophthalmoplegia (HP:0000590) | 1.86255625 |
| 133 | Chest pain (HP:0100749) | 1.85836126 |
| 134 | Autoimmune hemolytic anemia (HP:0001890) | 1.85827119 |
| 135 | Exercise-induced myalgia (HP:0003738) | 1.85426403 |
| 136 | Increased CSF protein (HP:0002922) | 1.84993237 |
| 137 | Mutism (HP:0002300) | 1.84542043 |
| 138 | Ureteral duplication (HP:0000073) | 1.84343716 |
| 139 | Supraventricular tachycardia (HP:0004755) | 1.84302676 |
| 140 | Hypoplasia of the radius (HP:0002984) | 1.83662445 |
| 141 | Facial cleft (HP:0002006) | 1.83023939 |
| 142 | Petechiae (HP:0000967) | 1.82895198 |
| 143 | Disinhibition (HP:0000734) | 1.82471926 |
| 144 | Oral leukoplakia (HP:0002745) | 1.81912953 |
| 145 | Atresia of the external auditory canal (HP:0000413) | 1.81372327 |
| 146 | Abnormality of the carotid arteries (HP:0005344) | 1.80969734 |
| 147 | Short thumb (HP:0009778) | 1.80893339 |
| 148 | Prolonged neonatal jaundice (HP:0006579) | 1.80876444 |
| 149 | Tracheoesophageal fistula (HP:0002575) | 1.80719337 |
| 150 | Hepatic necrosis (HP:0002605) | 1.80240496 |
| 151 | Multiple enchondromatosis (HP:0005701) | 1.80178462 |
| 152 | Deviation of the thumb (HP:0009603) | 1.79757878 |
| 153 | Rhabdomyosarcoma (HP:0002859) | 1.79521990 |
| 154 | Slender long bone (HP:0003100) | 1.79166721 |
| 155 | Asymmetric septal hypertrophy (HP:0001670) | 1.79128831 |
| 156 | Missing ribs (HP:0000921) | 1.78894570 |
| 157 | Supraventricular arrhythmia (HP:0005115) | 1.77564495 |
| 158 | Progressive microcephaly (HP:0000253) | 1.76898486 |
| 159 | Sparse lateral eyebrow (HP:0005338) | 1.76395045 |
| 160 | Primary atrial arrhythmia (HP:0001692) | 1.76048726 |
| 161 | Eczematoid dermatitis (HP:0000976) | 1.75542416 |
| 162 | Arterial thrombosis (HP:0004420) | 1.75330122 |
| 163 | Abnormality of T cell physiology (HP:0011840) | 1.74585004 |
| 164 | Bundle branch block (HP:0011710) | 1.74041295 |
| 165 | Eosinophilia (HP:0001880) | 1.73980450 |
| 166 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.73564479 |
| 167 | Pallor (HP:0000980) | 1.72830142 |
| 168 | Muscle fibrillation (HP:0010546) | 1.72730910 |
| 169 | Abnormal glycosylation (HP:0012345) | 1.72679936 |
| 170 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72679936 |
| 171 | Entropion (HP:0000621) | 1.72599024 |
| 172 | Secondary amenorrhea (HP:0000869) | 1.72505235 |
| 173 | Short 4th metacarpal (HP:0010044) | 1.71275929 |
| 174 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.71275929 |
| 175 | Stillbirth (HP:0003826) | 1.71273704 |
| 176 | Abnormality of reticulocytes (HP:0004312) | 1.71070445 |
| 177 | Calcaneovalgus deformity (HP:0001848) | 1.70928781 |
| 178 | Muscle fiber atrophy (HP:0100295) | 1.69007450 |
| 179 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.66668307 |
| 180 | Triphalangeal thumb (HP:0001199) | 1.66605093 |
| 181 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66500833 |
| 182 | Duplicated collecting system (HP:0000081) | 1.65814036 |
| 183 | Type I transferrin isoform profile (HP:0003642) | 1.65588059 |
| 184 | Premature ovarian failure (HP:0008209) | 1.65564285 |
| 185 | Lymphoma (HP:0002665) | 1.65561639 |
| 186 | Abnormal trabecular bone morphology (HP:0100671) | 1.65398096 |
| 187 | Spinal muscular atrophy (HP:0007269) | 1.65236021 |
| 188 | Increased nuchal translucency (HP:0010880) | 1.65160719 |
| 189 | Prominent nose (HP:0000448) | 1.65009095 |
| 190 | Proximal placement of thumb (HP:0009623) | 1.63965969 |
| 191 | Abnormality of the duodenum (HP:0002246) | 1.62606413 |
| 192 | Absent epiphyses (HP:0010577) | 1.61409599 |
| 193 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.61409599 |
| 194 | Abnormal number of incisors (HP:0011064) | 1.61378540 |
| 195 | Macrocytic anemia (HP:0001972) | 1.59578061 |
| 196 | Cellular immunodeficiency (HP:0005374) | 1.58660054 |
| 197 | Deformed tarsal bones (HP:0008119) | 1.58017977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.06126343 |
| 2 | WEE1 | 3.09505331 |
| 3 | TSSK6 | 2.83538060 |
| 4 | CDC7 | 2.72976032 |
| 5 | PLK4 | 2.63795312 |
| 6 | TAOK3 | 2.54631160 |
| 7 | BRSK2 | 2.47175432 |
| 8 | NEK2 | 2.31745828 |
| 9 | TBK1 | 2.17575391 |
| 10 | SRPK1 | 2.16382121 |
| 11 | EIF2AK1 | 2.11191582 |
| 12 | MAP3K13 | 2.01347602 |
| 13 | EIF2AK3 | 1.99081306 |
| 14 | ZAK | 1.94884163 |
| 15 | MKNK1 | 1.93024961 |
| 16 | NME2 | 1.92374277 |
| 17 | TTK | 1.90320271 |
| 18 | MKNK2 | 1.85145024 |
| 19 | BRD4 | 1.84768551 |
| 20 | PLK1 | 1.84425462 |
| 21 | CDK12 | 1.80685728 |
| 22 | RPS6KA4 | 1.80448401 |
| 23 | SIK2 | 1.73812950 |
| 24 | MOS | 1.72902604 |
| 25 | ACVR1B | 1.69041484 |
| 26 | PASK | 1.68096665 |
| 27 | PINK1 | 1.59354229 |
| 28 | STK38L | 1.55009787 |
| 29 | CDK7 | 1.50236422 |
| 30 | EPHA2 | 1.48162536 |
| 31 | ATR | 1.48083638 |
| 32 | PLK3 | 1.48064083 |
| 33 | IRAK1 | 1.48043367 |
| 34 | IKBKE | 1.44007076 |
| 35 | VRK1 | 1.43524351 |
| 36 | AURKB | 1.38750946 |
| 37 | TTN | 1.36576008 |
| 38 | BCKDK | 1.36158598 |
| 39 | MAP2K3 | 1.32840890 |
| 40 | BRSK1 | 1.32228011 |
| 41 | DYRK3 | 1.30655554 |
| 42 | STK10 | 1.29329333 |
| 43 | IRAK2 | 1.27769693 |
| 44 | STK4 | 1.25176936 |
| 45 | MAP3K5 | 1.24782649 |
| 46 | CHEK2 | 1.24769560 |
| 47 | GRK7 | 1.23974067 |
| 48 | TESK2 | 1.21167563 |
| 49 | TLK1 | 1.20953062 |
| 50 | STK16 | 1.20255316 |
| 51 | RPS6KB2 | 1.19999322 |
| 52 | PRPF4B | 1.19957543 |
| 53 | CDK4 | 1.19598485 |
| 54 | TESK1 | 1.17390186 |
| 55 | FRK | 1.15186046 |
| 56 | NEK1 | 1.13911678 |
| 57 | ARAF | 1.13551772 |
| 58 | MAP2K6 | 1.13446454 |
| 59 | SIK3 | 1.08504613 |
| 60 | ERN1 | 1.06917586 |
| 61 | MARK3 | 1.06045557 |
| 62 | KSR2 | 1.05449357 |
| 63 | CHEK1 | 1.04302595 |
| 64 | PIM1 | 1.01440340 |
| 65 | RAF1 | 1.01002476 |
| 66 | AURKA | 1.00717575 |
| 67 | MAP4K1 | 1.00022395 |
| 68 | MAP3K1 | 0.99824401 |
| 69 | MAP3K8 | 0.99389572 |
| 70 | MAP3K3 | 0.98036022 |
| 71 | MAP3K10 | 0.96951940 |
| 72 | KDR | 0.95353078 |
| 73 | IRAK3 | 0.94454584 |
| 74 | TRPM7 | 0.92732650 |
| 75 | PIM2 | 0.92536591 |
| 76 | MAP3K14 | 0.91988182 |
| 77 | CLK1 | 0.91405975 |
| 78 | TGFBR1 | 0.90381976 |
| 79 | FES | 0.87571750 |
| 80 | PKN2 | 0.86668344 |
| 81 | LATS2 | 0.84805896 |
| 82 | EEF2K | 0.84359120 |
| 83 | BMPR2 | 0.83542844 |
| 84 | MAPK11 | 0.83481174 |
| 85 | EIF2AK2 | 0.83248468 |
| 86 | TXK | 0.82724072 |
| 87 | ABL2 | 0.80443902 |
| 88 | FLT3 | 0.79681327 |
| 89 | STK3 | 0.79572394 |
| 90 | CSK | 0.77984929 |
| 91 | ZAP70 | 0.77962656 |
| 92 | CHUK | 0.76139087 |
| 93 | AKT3 | 0.75941279 |
| 94 | NEK9 | 0.75156256 |
| 95 | RIPK4 | 0.74520385 |
| 96 | PAK4 | 0.72568813 |
| 97 | CDK2 | 0.70429243 |
| 98 | ATM | 0.70072180 |
| 99 | ITK | 0.69871647 |
| 100 | SYK | 0.67954262 |
| 101 | PDK1 | 0.67072777 |
| 102 | HCK | 0.65438098 |
| 103 | MAPK12 | 0.63253709 |
| 104 | JAK3 | 0.61477370 |
| 105 | OBSCN | 0.61329852 |
| 106 | RPS6KA1 | 0.61170338 |
| 107 | MELK | 0.60961037 |
| 108 | TAOK1 | 0.58701659 |
| 109 | CDK8 | 0.57995976 |
| 110 | PAK1 | 0.57963604 |
| 111 | RPS6KC1 | 0.57501540 |
| 112 | RPS6KL1 | 0.57501540 |
| 113 | CSNK2A1 | 0.56517830 |
| 114 | ADRBK2 | 0.56366906 |
| 115 | ALK | 0.55402417 |
| 116 | RPS6KA5 | 0.54437197 |
| 117 | BRAF | 0.54398405 |
| 118 | BTK | 0.53679275 |
| 119 | RPS6KA6 | 0.53632137 |
| 120 | IKBKB | 0.53053923 |
| 121 | PDPK1 | 0.52646098 |
| 122 | LATS1 | 0.51806323 |
| 123 | PAK6 | 0.51712946 |
| 124 | CSNK2A2 | 0.51348461 |
| 125 | CAMK4 | 0.50955899 |
| 126 | KSR1 | 0.50665931 |
| 127 | PIK3CG | 0.50075489 |
| 128 | LCK | 0.49542037 |
| 129 | MAP3K9 | 0.49369327 |
| 130 | MARK2 | 0.48433351 |
| 131 | PRKCQ | 0.47964824 |
| 132 | JAK2 | 0.47785523 |
| 133 | TEC | 0.47588814 |
| 134 | LYN | 0.47204588 |
| 135 | NLK | 0.47076635 |
| 136 | TNK2 | 0.46555166 |
| 137 | SCYL2 | 0.46516561 |
| 138 | MTOR | 0.45467568 |
| 139 | CCNB1 | 0.45253652 |
| 140 | ERBB3 | 0.44941453 |
| 141 | CDK1 | 0.44927488 |
| 142 | MAP3K6 | 0.43586647 |
| 143 | PHKG1 | 0.43585263 |
| 144 | PHKG2 | 0.43585263 |
| 145 | CDK9 | 0.43568962 |
| 146 | PRKCI | 0.41708672 |
| 147 | TYK2 | 0.41704618 |
| 148 | BLK | 0.41696610 |
| 149 | LRRK2 | 0.40013413 |
| 150 | IRAK4 | 0.39970981 |
| 151 | MAP3K2 | 0.39942412 |
| 152 | MAP3K11 | 0.39137629 |
| 153 | TAOK2 | 0.38524078 |
| 154 | TGFBR2 | 0.37991142 |
| 155 | CAMKK2 | 0.36239997 |
| 156 | MAPKAPK3 | 0.35868869 |
| 157 | TIE1 | 0.35851236 |
| 158 | NEK6 | 0.35387519 |
| 159 | PDK2 | 0.35279118 |
| 160 | STK24 | 0.34849565 |
| 161 | PAK2 | 0.34563464 |
| 162 | PRKAA2 | 0.33945769 |
| 163 | KIT | 0.32777860 |
| 164 | PRKAA1 | 0.32146906 |
| 165 | PBK | 0.31692463 |
| 166 | MATK | 0.30319657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.96360190 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.60853456 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.56207750 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.40642634 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 2.96782904 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.94757826 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.87408141 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.84583650 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.63201385 |
| 10 | Cell cycle_Homo sapiens_hsa04110 | 2.53370245 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.52334236 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.43237085 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38443650 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.25318013 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23361499 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.21941410 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.20532461 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 2.19664717 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.19353729 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11032240 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.07078676 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.99576487 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.83872858 |
| 24 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.81135416 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.65355336 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.64690825 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.63728131 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.62780788 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47808226 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47710601 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45453293 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43672812 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42037677 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.40914555 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39128642 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.36750443 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29938237 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.29430903 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.29132290 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27370052 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26088913 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22872715 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21665721 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17394080 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.14631475 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.10794629 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08648940 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08333728 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.01393640 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01315026 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99772274 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98543993 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.98536572 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.97525607 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97092641 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96140142 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92048006 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90207687 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89258647 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89137021 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85582049 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.85119921 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84569144 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84448728 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83230583 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83050526 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82570045 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.82221922 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81456863 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79296474 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77071094 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.74859202 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73683170 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73196251 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72305315 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71594096 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71360387 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70746597 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70720755 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70466352 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70208327 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69489868 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69426919 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.68858029 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67811399 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67802799 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65485440 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64015075 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.63487080 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61431847 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60970443 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.60886718 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60751698 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58594592 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58459437 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57554024 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56573850 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56482239 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55885734 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54495084 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50972146 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50437060 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50386167 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49584947 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.49126906 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49034450 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48347570 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.48181902 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47646953 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47264256 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46878323 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.46415454 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.45633442 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45618727 |
| 115 | Allograft rejection_Homo sapiens_hsa05330 | 0.44142851 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44045374 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43805338 |
| 118 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43541830 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42410245 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41973324 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40873552 |
| 122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40796563 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.40050863 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39714753 |
| 125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39479030 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39448415 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38742035 |
| 128 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37310623 |
| 129 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.36805308 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36774349 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36772839 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36190599 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35429967 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35018258 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34697648 |
| 136 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.34693433 |
| 137 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33756582 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33489815 |
| 139 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32829696 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32043701 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.31665399 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30672365 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29105012 |
| 144 | Prostate cancer_Homo sapiens_hsa05215 | 0.27457674 |
| 145 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26788806 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26677966 |
| 147 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26415163 |
| 148 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25797277 |
| 149 | Asthma_Homo sapiens_hsa05310 | 0.24365379 |
| 150 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24042420 |
| 151 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22601901 |
| 152 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21778040 |
| 153 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21174021 |
| 154 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21067445 |
| 155 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.20905796 |
| 156 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20137451 |
| 157 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19395557 |

